Endothelium-independent relaxation of aortic rings by the nitric oxide synthase inhibitor diphenyleneiodonium

British Journal of Pharmacology

Volumn 120, Issue 5, 1997, Pages 857-864

  Dodd, Jeffrey M ^a   Zheng, Gemin ^a   Silverman, Howard S ^b   Lakatta, Edward G ^c   Ziegelstein, Roy C ^c  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Diphenyleneiodonium; Endothelium; Guanylate cyclase; Nitric oxide synthase; Vasodilatation

Indexed keywords

DIPHENYLIODONIUM SALT; GLIBENCLAMIDE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PRAZOSIN; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; TEMPERATURE DEPENDENCE; VASCULAR ENDOTHELIUM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLYBURIDE; HEAT; MALE; METHYLENE BLUE; MUSCLE RELAXATION; MUSCLE TONUS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ONIUM COMPOUNDS; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030903363     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701014     Document Type: Article

References (30)

1. G-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. , 160, 881-886.
2. BEASLEY, D. & MCGUIGGIN, M. (1994). Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J. Exp. Med. , 179,71-80.
3. CHARPIE, J. R. & WEBB, R. C. (1993). Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction. Biochem. Biophys. Res. Commun. , 194, 763-768.
4. DODD-O, J. MSILVERMAN, H. SZHENG, GLAKATTA, E. G. & ZIEGELSTEIN, R. C. (1995). The nitric oxide synthase inhibitor diphenyleneiodonium relaxes vascular smooth muscle and decreases cytosolic pH. J. Mol. Cell. Cardiol. , 27, A101 (Abstract).
5. GATLEY, S. J. & SHERRAT, H. S. A. (1976). The effects of diphenyleneiodonium on mitochondrial reactions. Biochem. J. , 158, 307-315.
6. HANSSON, G. KGENG, Y-JHOLM, J. HARDHAMMAR, PWENNMALM, A. & JENNISCHE, E. (1994). Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. , 180, 733-738.
7. KLATT, PSCHMIDT, KURAY, G. & MAYER, B. (1993). Multiple catalytic functions of brain nitric oxide synthase. J. Biol. Chem. , 268, 14781-14787.
8. MACNAUL, K. L. & HUTCHINSON, N. I. (1993). Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun. , 196, 1330- 1334.
9. MAYER, BBRUNNER, F. & SCHMIDT, K. (1993). Inhibition of nitric oxide synthesis by me;thylene blue. Biochem. Pharmacol. , 45, 367-374.
10. McCORD, J. M. & FRIDOVICH, I. (1970). The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J. Biol. Chem. , 245, 1374-1377.
11. MCGUIRE, J. JANDERSON, D. J. & BENNETT, B. M. (1994). Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate. J. Pharmacol. Exp. Ther. , 271, 708-714.
12. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med. , 329, 2002-2012.
13. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. , 6, 3051-3064.
14. PETTIBONE, D. JSWEET, C. SRISLEY, E. A. & KENNEDY, T. (1985). A structurally novel stimulator of guanylate cyclase with long-lasting hypotensive activity in the dog. Eur. J. Pharmacol. , 116, 307-312.
15. RAGAN, C. & BLOXHAM, D. P. (1977). Specific labeling of a constituent polypeptide of bovine heart mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone reductase by the inhibitor diphenyleneiodonium. Biochem. J. , 163, 605-615.
16. RAND, M. J. & LI, CO. (1993). The inhibition of nitric oxide-mediated relaxations in rat aorta and anococcygeus muscle by diphenyleneiodonium. Clin. Exp. Pharmacol. Physiol. , 20, 141-148.
17. REES, D. DPALMER, R. M. J. & MONCADA, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U. S. A. , 86, 3375-3378.
18. RODMAN, D. MMALLET, J. & McMURTRY, I. F. (1991). Difference in effect of inhibitors of energy metabolism on endothelium-dependent relaxation of rat pulmonary artery and aorta. Am. J. Respir. Cell. Mol. Biol. , 4, 237-242.
19. SCHINI, V. B. & VANHOUTTE, P. M. (1991). L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat. Circ. Res. , 68, 209-216.
20. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium, 113, 427-434.
21. SOMLYO, A. P. & SOMLYO, A. V. (1991). Smooth muscle structure and function. In The Heart and Cardiovascular System, ed. Fozzard, H. A. , Haber, E. , Jennings, R. B. , Katz, A. M. & Morgan, H. E. pp. 1295-1324. New York: Raven Press Ltd.
22. + channels in arterial smooth muscle. Science, 245, 177-180.
23. STUEHR, D. J. & IKEDA-SAITO, M. (1992). Spectral characterization of brain and macrophage nitric oxide synthases. J. Biol. Chem. , 267, 20547-20550.
24. STUEHR, D. JFASEHUN, O. AKWON, N. SGROSS, S. SGONZALEZ, J. ALEVI, R. & NATAHN, C. F. (1991). Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodoniura and its analogs. FASEB J. , 5, 98-103.
25. TSUKAHaRA, HGORDIENKO, D. V. & GOLIGORSKY, M. S. (1993). Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. , 193,722-729.
26. WANG, Y-XPOON, C. IPOON, K. S. & PANG, C. C. Y. (1993). Inhibitory actions of diphenyleneiodonium on endothelium-dependent vasodilations in vitro and in vivo. Br. J. Pharmacol. , 110,1232-1238.
27. G-nitro-L-arginine in pentobarbital-anesthetized rats. Life Sci. , 147, 2217-2224.
28. WANG, Y-X. & PANG, C. C. Y. (1993). Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardie effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J. Pharmacol Exp. Ther. , 265, 263-272.
29. WEIR, E. KWYATT, C. NREEVE, H. LHUANG, JARCHER, S. L. &. PEERS, C. (1994). Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J. Appl. Physiol. , 76, 2611-2615.
30. ZHANG, H. & COOK, D. (1994). Antagonism of eicosanoid-induced contraction of rat aorta by sulphonylureas. Pharmacology, 49, 173-183.